| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 06/06/2006 | US7056904 Therapy for bone disorders; osteoporosis; vitamin deficiency |
| 06/06/2006 | US7056903 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists |
| 06/06/2006 | US7056902 4-dedimethylamino tetracycline compounds |
| 06/06/2006 | US7056898 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 06/06/2006 | US7056698 Nucleic acids encoding interleukin-9 receptor variants |
| 06/06/2006 | US7056528 Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin |
| 06/06/2006 | US7056524 Methods of hydrating mucosal surfaces |
| 06/06/2006 | CA2327723C Bicyclic hydroxamic acid derivatives |
| 06/06/2006 | CA2166800C 4-substituted piperidine derivatives useful as neurokinin antagonists |
| 06/01/2006 | WO2006057932A2 2-METHYLENE-18,19-DINOR-1α-HYDROXY-HOMOPREGNACALCIFEROL AND ITS USES |
| 06/01/2006 | WO2006057902A2 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses |
| 06/01/2006 | WO2006057901A2 2-METHYLENE-19-NOR-1α-HYDROXY-17-ENE-HOMOPREGNACALCIFEROL AND ITS USES |
| 06/01/2006 | WO2006057900A2 17,20(z)-dehydro vitamin d analogs and their uses |
| 06/01/2006 | WO2006057899A2 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses |
| 06/01/2006 | WO2006057886A2 2-METHYLENE-19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND ITS USES |
| 06/01/2006 | WO2006057885A2 17,20(e)-dehydro vitamin d analogs and their uses |
| 06/01/2006 | WO2006057884A2 2α-METHYL AND 2ß-METHYL ANALOGS OF 19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND THEIR USES |
| 06/01/2006 | WO2006057270A1 Nitrogeneous tricyclic compound |
| 06/01/2006 | WO2006056848A1 Octahydropyrrolo[3,4-c]pyrrole derivatives |
| 06/01/2006 | WO2006056752A1 Phenoxyacetic acid derivatives useful for treating respiratory diseases |
| 06/01/2006 | WO2006056607A1 Substituted pteridines for treating inflammatory diseases |
| 06/01/2006 | WO2006056526A1 Inhalation medicament containing a novel anticholinesterase drug, formoterol and a steroid |
| 06/01/2006 | WO2006056471A1 5-hydroxy-benzothiazole derivatives having beta-2-adrenorecptor agonist activity |
| 06/01/2006 | WO2006056245A1 Use of a human chitinase-like protein in diagnosis and therapy |
| 06/01/2006 | WO2003025542A3 Immune response associated proteins |
| 06/01/2006 | US20060117414 Fad4, Fad5, Fad5-2, and Fad6, novel fatty acid desaturase family members and uses thereof |
| 06/01/2006 | US20060116518 Novel phenanthridines |
| 06/01/2006 | US20060116516 2-[[4-[[[4-(Aminosulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-4-methyl-5-thiazolecarboxylic acid, ethyl ester; 4-Methyl-2-[[4-[[[4-(methylsulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-5-thiazolecarboxylic acid, ethyl ester; Antiinflammatory agents; rheumatic diseases |
| 06/01/2006 | US20060116425 Methods and compositions for the treatment and prevention of lung disease |
| 06/01/2006 | US20060116388 CXCR3 antagonists |
| 06/01/2006 | US20060116145 Access parameter adaptation and packet data resource management using detailed mobile status information |
| 06/01/2006 | US20060115542 Therapeutic delivery of carbon monoxide |
| 06/01/2006 | US20060115470 Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders |
| 06/01/2006 | US20060115376 Irradiation in presence of stabilizer; preventing degradation |
| 06/01/2006 | US20060113968 Novel benzonaphthyridines |
| 06/01/2006 | US20060112589 Apparatus for treating particulate material |
| 06/01/2006 | DE202005009181U1 Pharmaceutical preparation (in liquid dosage form), useful for preventing, prophylaxis and/or treatment of e.g. cough (e.g. dry cough) and bronchial-inflammation/asthma, comprises Iceland moss and/or Malva together with non-toxic carriers |
| 06/01/2006 | DE102004057645A1 New substituted pteridine compounds, useful as phosphodiesterase 4 inhibitors for treating e.g. inflammatory diseases, cancer, asthma, ulcerative colitis, depression and schizophrenia |
| 06/01/2006 | DE102004057618A1 Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen Substituted pteridines for the treatment of inflammatory diseases |
| 06/01/2006 | CA2589209A1 Substituted pteridines for treating inflammatory diseases |
| 06/01/2006 | CA2588412A1 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses |
| 06/01/2006 | CA2588406A1 2-.alpha.-methyl and 2-.beta.-methyl analogs of 19,26,27-trinor-(20s-1.alpha.-hydroxyvitamin d3 and their uses |
| 06/01/2006 | CA2588401A1 17,20(z)-dehydro vitamin d analogs and their uses |
| 06/01/2006 | CA2588399A1 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses |
| 06/01/2006 | CA2588396A1 17,20(e)-dehydro vitamin d analogs and their uses |
| 06/01/2006 | CA2587141A1 Octahydropyrrolo[3,4-c]pyrrole derivatives |
| 06/01/2006 | CA2586553A1 Nasal sprayer containing a formulation with olopatadine |
| 06/01/2006 | CA2586443A1 5-hydroxy-benzothiazole derivatives having beta-2-adrenoreceptor agonist activity |
| 06/01/2006 | CA2582153A1 Inhalation medicament containing a novel anticholinesterase drug, formoterol and a steroid |
| 06/01/2006 | CA2579962A1 Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders |
| 05/31/2006 | EP1662003A2 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 05/31/2006 | EP1661915A1 Preparation of antibodies against the human chitinase-like protein GL008 |
| 05/31/2006 | EP1661892A1 Condensed ring compound and use thereof |
| 05/31/2006 | EP1661889A1 Chemokine receptor antagonist and medical use thereof |
| 05/31/2006 | EP1661572A1 Novel use of cannabinoid receptor agonist |
| 05/31/2006 | EP1661570A2 Compositions comprising ipatropium and xylometazoline for treatment of the common cold |
| 05/31/2006 | EP1660476A1 Haloalkyl- and piperidine-substituted benzimidazole-derivatives |
| 05/31/2006 | EP1660475A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 05/31/2006 | EP1660467A2 Aminofurazan compounds as protein kinase inhibitors |
| 05/31/2006 | EP1660461A1 Novel condensed n-pyrazinyl-sulphonamides and their use in the treatment of chemokine mediated diseases |
| 05/31/2006 | EP1660431A2 Phenoxyacetic acid derivatives |
| 05/31/2006 | EP1660132A1 Composition comprising a pulmonary surfactant and a pde2 inhibitor |
| 05/31/2006 | EP1660085A1 Pyridylpyrrole derivatives active as kinase inhibitors |
| 05/31/2006 | EP1660035A2 Liquid compositions comprising formoterol |
| 05/31/2006 | EP1419178B1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1270570B1 Amide compounds and use thereof |
| 05/31/2006 | EP1235851B1 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 05/31/2006 | EP1231270B1 Novel protein and dna thereof |
| 05/31/2006 | EP1163238B1 Chemokine recpetor binding heterocyclic compounds |
| 05/31/2006 | CN1780832A 5-phenylthiazole derivatives and their use as PI3 kinase inhibitors |
| 05/31/2006 | CN1780617A Imidazolin-2-ylaminophenyl amides as IP antagonists. |
| 05/31/2006 | CN1778375A Chinese medicine for treating chronic bronchitis |
| 05/31/2006 | CN1778374A Externally-applied Chinese medicine for treating acute and chronic pharyngolaryn gitis and its therapeutic belt thereof |
| 05/31/2006 | CN1778364A Colloidal ball for detoxication and anodyne |
| 05/31/2006 | CN1778315A Eijknisia flower honey and oral liquid |
| 05/31/2006 | CN1778291A Oral percarbonateamide oxygen-supply agent and preparation thereof |
| 05/31/2006 | CN1257905C Compounds for inhibiting the release of inflammatory cytokines |
| 05/31/2006 | CN1257886C Dehydroamino acids compounds |
| 05/31/2006 | CN1257748C Preparation and preparing method for asthenia diseases of breath and blood circulation systems |
| 05/31/2006 | CN1257746C Chinese herbal medicine preparation for treating bronchitis and laryngopharyngitis |
| 05/31/2006 | CN1257723C Powder injection for intravenous injection and its preparing method |
| 05/31/2006 | CN1257722C Intravenous transfusion for treating infection of upper respiratory tract and its preparing method |
| 05/30/2006 | US7053230 Administering a combination of an omega-3 fatty acid and aspirin, to a patient suffering from inflammation, arthritis or cardiovascular diseases |
| 05/30/2006 | US7053215 For therapy of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes |
| 05/30/2006 | US7053214 Tryptase inhibitor; antiinflammatory agents |
| 05/30/2006 | US7053213 Therapeutic heterocycles |
| 05/30/2006 | US7053176 Combination of C1-INH and lung surfactant for the treatment of respiratory disorders |
| 05/30/2006 | US7053120 Use of carboxy compounds such as 2(4-acetoxyphenyl)2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents |
| 05/30/2006 | US7053113 Mannich base prodrugs of 3-(pyrrol-2-yl-methylidene)-2-indolinone derivatives |
| 05/30/2006 | US7053103 A pyrazolo[3,4-B]pyridine derivatives; corticotropin releasing factor receptor antagonists; treating stress-related illnesses, mood disorders, eating disorders, stress-induced gastrointestinal dysfunctions, neurodegenerative diseases, and neuropsychiatric disorders |
| 05/30/2006 | US7053101 Orphan opioid receptor (orl-1) ligands; anxiety, depression, neuropathic and acute pain, migraines, asthma, improved cognition |
| 05/30/2006 | US7053099 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors |
| 05/30/2006 | US7053098 3,4-Dihydro-(1H) quinazolin-2-one compounds as CSBP/P38 kinase inhibitors |
| 05/30/2006 | US7053090 Antiinflammatory agents; antihistamines; skin disorders; antiarthritic agents; antidiabetic agents; autoimmune disease |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/30/2006 | US7053057 Caspase inhibitors and uses thereof |